[ad_1]
(WSMV) – A new recall is underway for popular antihypertensive medications because of contamination by an impurity that can cause cancer. It's the latest in a series of recalls, the third of this month and one of two dozen reminders since last year.
Teva Pharmaceuticals is recalling 35 lots of Losartan bulk 25 mg and 100 mg tablets of American potassium sold at Golden State Medical Supply. Golden State packages this product under its own label and distributes it in bottles of 30, 90 and 1000 tablets.
Losartan possassif is used in the treatment of hypertension, including hypertensive patients with left ventricular hypertrophy and nephrophathia in patients with type 2 diabetes.
To date, no adverse events related to the recalled batches have been reported and the recall is ongoing due to a precautionary measure.
The impurity in the drug is N-nitroso-N-methyl-4-ambinobutyric acid (NMBA). The impurity is greater than the limit of acceptable exposure of the FDA. The FDA added that "impurities" can occur when specific chemicals and reaction conditions are present in the drug's IPA manufacturing process. This can also result from the reuse of materials, such as solvents ". The FDA maintains that the risk of cancer was generally low.
If you are taking this medicine, you are advised not to stop taking it, as stopping without talking to a health professional can lead to immediate health problems. Talk to your doctor or health care provider about other treatments.
The initial recall took place on April 18, when Torrent Pharmaceuticals recalled 104 batches of Losartan tablets. The recall was then extended six days later by Legacy Pharmaceuticals.
To find out if you are affected by the last reminder, click here.
[ad_2]
Source link